#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma recurrent Alveolar rhabdomyosarcoma Oesophageal carcinoma Oesophageal squamous cell carcinoma stage III Mixed-type liposarcoma Colorectal adenocarcinoma Neurofibromatosis Peritoneal neoplasm Pulmonary alveolar haemorrhage Immune-mediated myositis Hyperoxaluria Insulinoma Hyperphagia Cardiac amyloidosis Parkinson's disease More trials…

    Learn about Rare Diseases

    Retinoblastoma – Life with Disease Ewing’s sarcoma metastatic Retinitis pigmentosa – Diagnostics Osteosarcoma metastatic – Diagnostics Basal cell naevus syndrome – Life with Disease Testicular leiomyosarcoma – Trials in Disease Crigler-Najjar syndrome Gaucher’s disease type I – Basic Information Pulmonary sarcoidosis – Basic Information Hereditary hypophosphataemic rickets – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Talazoparib Gentamicin Cefuroxime Sodium Fazirsiran Sunvozertinib Tigecycline 18F-Fludarabine CARBOMER 980 Gadoxetic Acid, Disodium Iptacopan Lenvatinib CARBACHOL Venglustat R-Azasetron Besilate Bifikafusp Alfa Atuliflapon Bms-986288 Dordaviprone Retinol Palmitate XMAB942 More therapies…

    Learn about Your Condition

    Stem cell transplant Schizophrenia Medication overuse headache Trisomy 21 Knee arthroplasty Hypersensitivity Foetal growth restriction Neutropenia Arterial stiffness Rectosigmoid cancer High-grade B-cell lymphoma Fatty acid oxidation disorder Primary amyloidosis Herpes simplex meningitis Pre-eclampsia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study Comparing Eltrombopag Tablets in Healthy Volunteers to Test if Two Forms of the Medicine Work the Same Way in the Body After Taking with Food

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Aplastic anaemia
    • Thrombocytopenia
    Portugal

  • A study using the radiotracer vercirnon to examine its distribution in the body of healthy participants for research on Crohn’s disease

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • VERCIRNON
    Sweden

  • A study comparing how ritlecitinib capsules work when sprinkled on food versus swallowed whole and with or without food in healthy adults

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Vitiligo
    • Alopecia areata
    • Colitis ulcerative
    Belgium

  • A study to test how BI 1291583 is broken down and removed from the body in healthy men

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Bi 1291583
    The Netherlands

  • A study comparing blood levels of finerenone when taken as one 40 mg tablet versus two 20 mg tablets in healthy male participants

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Heart failure with reduced ejection fraction
    Investigated Drugs:
    • Finerenone
    Germany

  • A study to assess how SAR443820 is absorbed, broken down and removed by the body in healthy adult men

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • SAR443820
    The Netherlands
Previous Page
1 … 935 936 937 938 939 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!